Human Immunodeficiency Virus (HIV): Pathogenesis, Latency and Support
A retroviral pathogenesis brief on how HIV enters CD4+ T-cells, copies its RNA into DNA, integrates into host chromosomes, forms a latent reservoir, and responds to antiretroviral therapy.
Submitted research brief - Submitted to OwieClear; written with an AI assistant - November 2026
Read this first. This document was written outside OwieClear and has not been reviewed by a clinician. We publish it so you can read the source for yourself. It is educational and is not medical advice. Where our own pages disagree with it, follow our pages, which cite their sources, and ask a healthcare professional about anything that affects your care.
What we found that needs correcting
- The nutrition section is the weakest part of the brief and needs the most care. Correcting a measured deficiency, such as vitamin D, B12, zinc or selenium, is ordinary and sensible medicine. Beyond that, the listed items are not supported: glutamine and probiotic trials in HIV have moved laboratory markers without showing better health outcomes, and N-acetylcysteine raises glutathione without any trial showing improved immune recovery or survival. None of this substitutes for antiretroviral therapy, and the brief should not be read as suggesting it supplements it in any proven way.
- Selenium deserves a specific warning the brief does not give. The gap between a helpful amount and a harmful one is narrow, and too much causes hair and nail loss, nerve damage and gastrointestinal illness.
- Supplement interactions are missing entirely, and they are clinically important. Calcium, magnesium, iron and zinc bind integrase inhibitors in the gut and can lower drug levels enough to matter, which is why dosing has to be separated in time. St John's wort can cause outright treatment failure. Anyone taking HIV medicine should tell their clinician or pharmacist about every supplement they take.
- U=U is stated without its boundary. The evidence that an undetectable viral load means no transmission is for sexual transmission. Risk through shared injecting equipment and through breastfeeding is greatly reduced but is not established as zero, and the breastfeeding figure is under 1 percent rather than nil.
- The AIDS stage is defined in the brief by a CD4 count below 200 alone. The clinical definition is a CD4 count below 200 or the presence of certain AIDS-defining illnesses at any CD4 count.
- Clinical latency is described as 'years to decades'. Without treatment the median is closer to eight to ten years; decades is the exception, not the range. The brief also calls the virus quiet in this stage, where in fact replication and immune activation continue throughout, and that ongoing inflammation is part of what drives later heart and organ disease.
- The treatment list is dated. Most first-line regimens now pair two reverse transcriptase inhibitors with an integrase inhibitor; protease inhibitors are much less common first-line than the brief implies. Capsid inhibitors are a newer class the brief does not mention, and lenacapavir, given twice a year, was approved for prevention in June 2025 and recommended by the CDC in September 2025.
- A small technical point: protease does its cutting during and after budding, as the particle matures, rather than before budding as the brief states. The sequence matters because it is exactly where protease inhibitors act.
- Most coreceptor use is described as if CCR5 and CXCR4 were interchangeable. Nearly all newly transmitted virus uses CCR5, and CXCR4-using virus tends to appear later in untreated infection. That distinction is the whole basis of the CCR5-delta32 stem cell transplant cures.
- The core virology in the brief is accurate: the entry sequence through CD4 and a coreceptor, reverse transcription without proofreading and the resulting quasispecies, integration by integrase and the formation of a latent reservoir in resting cells, the massive early loss of CD4 cells in gut-associated lymphoid tissue, and the requirement for lifelong therapy.
Download the PDF
Our reviewed pages on this
All source documents